click below
click below
Normal Size Small Size show me how
PHO 3
BDK
| Generic Name | Brand Name | Pharmacologic Category | Common Indication | Key Side Effects | Other Notes | US Boxed Warning | Classification |
|---|---|---|---|---|---|---|---|
| Methotrexate | Trexall | Antimetabolite (folic acid antagonist) | Rheumatoid arthritis, Crohn's Disease, Psoriasis, Various hematologic & solid tumors | Stomatitis, Diarrhea, Nausea, Vomiting, Thrombocytopenia, Leukopenia, Increased hepatic transaminases, Pulmonary fibrosis (rare) | Folic acid supplementation may be taken during use to reduce hematologic, gastrointestinal, and hepatic side effects | Serious toxic rxns;fetal death &/or congenital abnormalities (avoid in pregnancy);severe bone marrow suppression, aplastic anemia & toxicity have been reported w/ methotrexate & NSAIDs;hepatotoxicity;methotrexate-induced lung disease;GI toxicity w/ NSAID | N/A |
| Cisplatin | Kemoplat | Antineoplastic agent, platinum-based compound | Advanced bladder, ovarian, & testicular cancer; Various cancers | Bone marrow suppression, Nausea, Vomiting, Nephrotoxicity, Neurotoxicity, Ototoxicity | N/A | May cause severe myelosuppression, nausea and vomiting, renal toxicity, and dose-related neuropathy | N/A |
| Doxorubicin | Adriamycin | Antineoplastic agent, anthracycline | Adjuvant therapy for breast cancer, Various cancers | Cardiomyopathy, Alopecia, Nausea, Vomiting, Bone marrow suppression | May cause red discoloration of urine, tears, sweat, & saliva | May cause cardiomyopathy, myelosuppression, secondary malignancies; extravasation can result in severe local tissue injury and necrosis | N/A |
| Pembrolizumab | Keytruda | Antineoplastic agent, monoclonal antibody | Various cancers | Peripheral edema, Pruritus, Skin rash, Endocrine & metabolic abnormalities, Constipation, Diarrhea, Nausea, Vomiting, Hematuria, Anemia, Increased liver enzymes, Fatigue, Musculoskeletal pain, Increased SCr, Dyspnea | N/A | N/A | N/A |
| Anastrozole | Arimidex | Aromatase inhibitor | Hormone receptor-positive breast cancer | Fatigue, Rash, Flushing, Hot flashes, Arthralgia, Nausea, Vomiting, HTN, Peripheral edema, Osteoporosis | CV side effects (i.e hypercholesterolemia, CAD); Fetal toxicity (CI in pregnancy) | N/A | N/A |
| Tamoxifen | Soltamox | Selective estrogen receptor modulator (SERM) | Hormone receptor-positive breast cancer | Hot flashes/night sweats, Vaginal bleeding/discharge, Decreased bone density (in premenopausal females) | Contraception should be used in premenopausal females due to teratogenicity of the drug; Don't use w/ warfarin or history DVT/PE | Increased risk for uterine or endometrial cancer & thromboembolic events | N/A |